Nutritional Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
YouTube link: https://youtu.be/HxHUUDOy_sU
Recent research has shown that ADPKD is a metabolic disease and that the cells affected in ADPKD exhibit distinct metabolic abnormalities that drive disease progression. Individuals with ADPKD have metabolic abnormalities that can be addressed by nutritional management as detailed below. The specific nutritional interventions that are addressed with KetoCitra are provided by supplementing patients with two natural compounds, beta-hydroxybutyrate (BHB) and citric acid (citrate), in a formulation that also delivers beneficial minerals and an alkaline load.